Maury Raycroft

Stock Analyst at Jefferies

(1.61)
# 3,425
Out of 5,182 analysts
59
Total ratings
35.56%
Success rate
-1.94%
Average return

Stocks Rated by Maury Raycroft

Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32$43
Current: $36.92
Upside: +16.47%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66$81
Current: $87.16
Upside: -7.07%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114$63
Current: $23.99
Upside: +162.61%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7$0.5
Current: $0.28
Upside: +78.44%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108$134
Current: $125.68
Upside: +6.62%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10$21
Current: $16.37
Upside: +28.28%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2$1.6
Current: $1.20
Upside: +33.33%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550$549
Current: $308.51
Upside: +77.95%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18$7
Current: $7.29
Upside: -3.98%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $44.11
Upside: -65.99%
Initiates: Hold
Price Target: $3.5
Current: $1.72
Upside: +103.49%
Maintains: Buy
Price Target: $70$53
Current: $10.08
Upside: +425.79%
Maintains: Buy
Price Target: $7$8
Current: $1.79
Upside: +346.93%
Maintains: Buy
Price Target: $7$3
Current: $0.21
Upside: +1,328.57%
Initiates: Buy
Price Target: $6
Current: $19.15
Upside: -68.67%
Initiates: Buy
Price Target: $19
Current: $26.33
Upside: -27.84%
Assumes: Buy
Price Target: $23$15
Current: $3.67
Upside: +308.72%
Initiates: Buy
Price Target: $180
Current: $17.93
Upside: +903.90%
Initiates: Buy
Price Target: $23
Current: $1.49
Upside: +1,448.82%
Initiates: Buy
Price Target: $195
Current: $1.72
Upside: +11,237.21%
Upgrades: Buy
Price Target: $11
Current: $8.90
Upside: +23.60%
Downgrades: Hold
Price Target: $32$6
Current: $37.28
Upside: -83.91%
Maintains: Buy
Price Target: $92$75
Current: $73.60
Upside: +1.90%
Initiates: Buy
Price Target: $11
Current: $3.31
Upside: +232.33%
Downgrades: Hold
Price Target: $38$5
Current: $1.56
Upside: +220.51%
Initiates: Buy
Price Target: $36
Current: $5.49
Upside: +555.74%
Initiates: Buy
Price Target: $105
Current: $7.50
Upside: +1,300.00%
Upgrades: Buy
Price Target: $172
Current: $50.99
Upside: +237.32%
Initiates: Buy
Price Target: $47
Current: $2.92
Upside: +1,509.59%
Maintains: Buy
Price Target: $36$42
Current: $13.04
Upside: +222.09%